Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP in Pulmonary Hypertension with Acute Exacerbation of Chronic Pulmonary Disease
NCT02742909Phase 4Completed
- Start
- Dec 2015
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nesiritide in pulmonary hypertension (PH). Primary endpoint: Pulmonary Artery Systolic Pressure at 30 hours. Started Dec 2015; status: completed.
02
Drugs
nesiritide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02742909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742909.